Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2017Q4 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2017Q3 $ vs. 2017Q3
NEUROCRINE BIOSCIENCES INC 5,151,589 $399,712,000 13.25% +360,000 +$106,083,000
AMICUS THERAPEUTICS, INC. 17,888,597 $257,417,000 8.53% No Change -$12,343,000
Global Blood Therapeutics, Inc. 4,889,066 $192,384,000 6.38% +625,000 +$59,985,000
ALNYLAM PHARMACEUTICALS, INC. 1,330,802 $169,079,000 5.60% -458,000 -$41,088,000
ZOGENIX, INC. 3,970,357 $160,799,000 5.33% +300,000 +$32,153,000
LA JOLLA PHARMACEUTICAL CO PAR $.0001 2 3,388,611 $109,046,000 3.61% New +$109,046,000
Blueprint Medicines Corp 1,140,434 $86,000,000 2.85% +715,773 +$56,414,000
ANAPTYSBIO, INC 756,387 $76,183,000 2.53% -225,882 +$41,853,000
PUMA BIOTECHNOLOGY, INC. 703,820 $69,573,000 2.31% -220,000 -$41,054,000
ACCELERON PHARMA INC 1,616,259 $68,594,000 2.27% No Change +$8,275,000
Retrophin, Inc. 2,672,525 $56,310,000 1.87% -13,679 -$10,549,000
CORIUM INTL INC 5,847,133 $56,191,000 1.86% No Change -$8,595,000
AVEXIS INC 480,141 $53,137,000 1.76% -191,040 -$11,786,000
CytomX Therapeutics, Inc. 2,490,381 $52,571,000 1.74% +1,100,000 +$27,308,000
DOVA PHARMACEUTICALS INC 1,809,015 $52,099,000 1.73% +55,000 +$9,512,000
REGENXBIO Inc. 1,421,186 $47,254,000 1.57% -20,000 -$233,000
VBI Vaccines Inc/BC 9,665,843 $41,273,000 1.37% +3,100,000 +$15,995,000
ABIOMED INC 215,000 $40,293,000 1.34% +163,271 +$31,571,000
IOVANCE BIOTHERAPEUTICS, INC. 4,776,114 $38,208,000 1.27% +50,000 +$1,581,000
MERIT MEDICAL SYSTEMS INC 874,013 $37,757,000 1.25% +774,013 +$33,522,000
ARGENX SE SPONSORED ADR 537,361 $33,929,000 1.12% New +$33,929,000
Alector, Inc. 1,320,000 $33,792,000 1.12% +475,000 +$16,089,000
TELEFLEX INC 125,900 $31,326,000 1.04% +70,700 +$17,969,000
MyoKardia, Inc. 710,726 $29,922,000 0.99% +160,009 +$6,324,000
Quotient Ltd 6,033,020 $29,683,000 0.98% +2,306,034 +$11,309,000